Special Issue "Efflux Pumps of Multi-Drug Resistant Pathogenic Bacteria: Their Genetic Regulation, Molecular Biology and Possible Control with Newly Designed Agents"

Quicklinks

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: closed (31 December 2012)

Special Issue Editor

Guest Editor
Prof. Dr. Leonard Amaral
Travel Medicine, Center for Malaria and Tropical Disease (CMDT), Institute of Hygiene & Tropical Medicine, Universidade Nova de Lisboa, Rua Junqueira 100, 1349-008 Lisbon, Portugal
Website: http://publicationslist.org/lamaral
E-Mail: lamaral@ihmt.unl.pt
Interests: antibiotic resistance; multi-drug resistance; bacterial infections; efflux pumps; reversal of resistance; MDR/XDR Tb; therapy; molecular genetics; molecular biology; drug discovery

Special Issue Information

Dear Colleagues,

Multi-drug resistance of pathogenic bacterial clinical isolates is now known to be mainly due to over-expressed efflux pumps that result from therapy with antibiotics that is either ineffective or improperly administered [1]. The development of the MDR phenotype is thus problematic to therapy since resistance to the antibiotic initially used also bestows resistance to antibiotics of the same class and or other classes of antibiotics [1,2]. For the past two decades, much has been learned about the regulation and control of efflux pumps that render the clinical isolate with an MDR phenotype. Nevertheless, at this time, although many compounds have been identified to affect the activity of the over-expressed efflux pump of a given MDR bacterium and therefore render the antibiotic bacterium susceptible to antibiotics to which it was initially resistant, none have yet to reach the market as adjuncts to antibiotic therapy. The special issue of “Antibiotics” "Efflux pumps of multi-drug resistant pathogenic bacteria: Their genetic regulation, molecular biology and possible control with newly designed agents." will receive contributions from experts in the field of efflux pumps, their regulation and potential control with newly discovered agents from natural and chemically derived sources. We hope that those who are conducting research in this area will also submit their contributions for publication in this special issue.

1. Amaral, L.; Fanning, S.; Pagès, J.M. Efflux pumps of gram-negative bacteria: Genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. Adv. Enzymol. Relat. Areas Mol. Biol. 2011, 77, 61–108. Review.
2. Pagès, J.M.; Amaral, L. Fanning, S. An original deal for new molecule: Reversal of efflux pump activity, a rational strategy to combat Gram-negative resistant bacteria. Curr. Med. Chem. 2011, 18, 2969–2680.

Prof. Dr. Leonard Amaral
Guest Editor

Published Papers (8 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-8
p. 182-190
by  and
Antibiotics 2013, 2(2), 182-190; doi:10.3390/antibiotics2020182
Received: 14 January 2013; in revised form: 18 March 2013 / Accepted: 22 March 2013 / Published: 27 March 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (444 KB) | HTML Full-text | XML Full-text
p. 163-181
by  and
Antibiotics 2013, 2(1), 163-181; doi:10.3390/antibiotics2010163
Received: 28 December 2012; in revised form: 5 March 2013 / Accepted: 11 March 2013 / Published: 18 March 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (377 KB) | HTML Full-text | XML Full-text
p. 83-99
by , , , , ,  and
Antibiotics 2013, 2(1), 83-99; doi:10.3390/antibiotics2010083
Received: 15 January 2013; in revised form: 4 March 2013 / Accepted: 5 March 2013 / Published: 13 March 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (575 KB) | HTML Full-text | XML Full-text | Supplementary Files
p. 73-82
by , ,  and
Antibiotics 2013, 2(1), 73-82; doi:10.3390/antibiotics2010073
Received: 14 January 2013; in revised form: 16 February 2013 / Accepted: 1 March 2013 / Published: 11 March 2013
Show/Hide Abstract | PDF Full-text (330 KB) | HTML Full-text | XML Full-text
p. 58-72
by , ,  and
Antibiotics 2013, 2(1), 58-72; doi:10.3390/antibiotics2010058
Received: 26 December 2012; in revised form: 28 January 2013 / Accepted: 31 January 2013 / Published: 18 February 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (358 KB)
p. 28-45
by ,  and
Antibiotics 2013, 2(1), 28-45; doi:10.3390/antibiotics2010028
Received: 4 January 2013; in revised form: 29 January 2013 / Accepted: 30 January 2013 / Published: 5 February 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (464 KB) | HTML Full-text | XML Full-text
p. 11-27
by , , , , , , , , ,  and
Antibiotics 2013, 2(1), 11-27; doi:10.3390/antibiotics2010011
Received: 24 December 2012; in revised form: 16 January 2013 / Accepted: 16 January 2013 / Published: 22 January 2013
Show/Hide Abstract | PDF Full-text (669 KB) | HTML Full-text | XML Full-text | Supplementary Files
p. 29-43
by ,  and
Antibiotics 2012, 1(1), 29-43; doi:10.3390/antibiotics1010029
Received: 29 October 2012; in revised form: 16 November 2012 / Accepted: 16 November 2012 / Published: 21 November 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (509 KB) | HTML Full-text | XML Full-text
Select/unselect all
Displaying article 1-8
Select articles Export citation of selected articles as:

Last update: 20 February 2014

Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert